News & Commentary

Latest News Features

Biopharmaceutical company Epizyme sets terms for $60 million IPO
Eaton Vance Senior Floating-Rate Fund (EFR) Ex-Dividend Date Scheduled for May 22, 2013
Eaton Vance Tax-Managed Diversified Equity Income Fund (ETY) Ex-Dividend Date Scheduled for May 22, 2013
Flaherty & Crumrine Preferred Securities Income Fund Inc (FFC) Ex-Dividend Date Scheduled for May 22, 2013

3M Company (MMM) Ex-Dividend Date Scheduled for May 22, 2013

3M Company ( MMM ) will begin trading ex-dividend on May 22, 2013. A cash dividend payment of $0.635 per share is scheduled to be paid on June 12, 2013. Shareholders who purchased MMM stock [...]

Read Full Story

Latest News Videos

Apple and Google Dominate Global Br...

Vodafone's Verizon Dilemma

Tumblr Puts Focus on NY Tech Scene

Mad Money Uncovered: CREE Is In

Moving the Market

Market Summary |

Stocks On The Move

5/21/2013 10:00 AM ET

[BRIEFING.COM][BRIEFING.COM] The major indices have notched fresh highs with the Dow leading the way. The blue chip index trades higher by 0.4% as Home Depot (HD 78.84, +2.08) and JPMorgan Chase (JPM 53.39, +1.10) provide notable support. On the...

[more]

Stock Market Headlines

Brazil Stocks Open Mixed as Embraer Climbs, HRT Plunges 10:18AM ET - Dow Jones Business News

Correction to TJX Earnings Report 10:07AM ET - Dow Jones Business News

Synergy Pharmaceuticals Presents Plecanatide Results From a Large Multicenter Clinical Study at Lat 10:00AM ET - GlobeNewswire

Moneygram International, Inc. [MGI] to Ring The NASDAQ Stock Market Opening Bell 10:00AM ET - GlobeNewswire

UPDATE: Medtronic 4th-Quarter Sales Rise 4%, Offset by Restructuring Costs 9:54AM ET - Dow Jones Business News

View All

Browse News by Category

Business

More Business

Economy

More Economy

Technology

More Technology

U.S. Markets

More U.S. Markets

International

More International

Initial Public Offerings (IPOs)

More IPOs

RSS user? View available RSS feeds in News.

Market Currents

Real-time news and commentary for investors

10:30 AM Coppersmith Capital Management (5.8% stake) wants Alere ([[ALR]] -0.9%) to consider selling its drug testing business for ~$2.5B in order to pay down debt, according to Reuters, citing people familiar with the matter. This wouldn't be Coppersmith's first call for asset sales: the investment firm has said publicly that ALR should either sell or shutter its health management business.
See All Market Currents